Medical News from FDA US Food & Drug

FDA warns about illegal use of injectable silicone for body contouring and associated health risks

November 14, 2017, 6:59 am by FDA US Food & Drug

FDA issues safety communication about illegal use of injectable silicone for body contouring and associated health risks


Featured Medical Stories

Newest Fitbits

Have you seen the NEW FITBIT??

Fitbit is now a health tracker and fasion statement. See all the new beautiful models here >> See the HOTTEST new Fitbits!

See the HOT Fitbit Blaze Now Compare All Fitbit Products Google Fitbit
Sense Sleep Tracker

Awaken Your Sleeping Beauty With This Sleep Tracker

Sleep is the new hot topic and from what science tells us, it is the holy grail of health. If you can track it, you can optimize it. If you can optimize it, you can benefit from it. This hot new sleep tracker by Hello is the perfect sleep tracker for the perfect price. There is beauty in health, and it needs to be awakened. But before that, let's get the best sleep of our lives. Learn more here: Sense Sleep Tracker on Amazon

Sleep Tracker on Amazon Sleep Tracker Reviews Google Sleep Trackers

More medical news from FDA US Food & Drug

FDA permits marketing of first catheter-based systems used to create vascular access for hemodialysis patients
FDA US Food & Drug : June 22, 2018, 9:55 am
FDA permits marketing of first catheter-based systems used to create vascular access for hemodialysis patients

FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes
FDA US Food & Drug : June 21, 2018, 12:34 pm
glucose monitoring system, implantable glucose sensor, adults, diabetes

FDA approves automated insulin delivery and monitoring system for use in younger pediatric patients
FDA US Food & Drug : June 21, 2018, 2:10 am
FDA approves automated insulin delivery and monitoring system for use in younger pediatric patients

Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products
FDA US Food & Drug : June 19, 2018, 12:03 pm
Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products

Statement from FDA Commissioner Scott Gottlieb, M.D., on new guidance to help manufacturers implement protections against potential attacks on the U.S. food supply
FDA US Food & Drug : June 19, 2018, 7:27 am
FDA releases draft guidance to help food manufacturers implement the Intentional Adulteration rule under the FDA Food Safety Modernization Act